osimertinib
Feb 10, 2022
AstraZeneca Q4 Oncology Revenues Grow 20 percent
Nov 12, 2021
AstraZeneca's Q3 Oncology Revenues Grow 18 Percent
Jul 29, 2021
AstraZeneca Q2 Revenues Increase 31 Percent
Jun 7, 2021